InsidersTradesSigma
Follow the Alliqua BioMedical, Inc. stock price and the full management transaction log of the company, a listed issuer based in United States. Shares trade on the US market, under the authority of SEC (Form 4). Market capitalisation: €2.3bn. The latest transaction was reported on 11 February 2016 (Attribution). Among the most active insiders: BARTON BRADFORD. All data is openly available.
Analysts rate Alliqua BioMedical, Inc. Strong Buy (bullish), based on 12 analysts. Average price target: US$59.30.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
4 of 4 declarations
Alliqua BioMedical, Inc. is a company focused on developing healthcare products, particularly in the field of biomaterials and advanced therapies. It is listed on the XNAS market.